Quinidine detailed information

Quinidine detailed information

Clinical data
Synonyms	(2-ethenyl-4-azabicyclo[2.2.2]oct-5-yl)- (6-methoxyquinolin-4-yl)-methanol 6'-methoxycinchonan-9-ol 6' methoxy-alpha (5-vinyl-2-quinuclidinyl)-4-quinoline methanol
Routes of administration	Oral
ATC code	C01BA01 (WHO)
Pharmacokinetic data
Bioavailability	70-80%
Metabolism	50-90% Hepatic
Elimination half-life	6-8h
Excretion	Renal
Identifiers
IUPAC name 2-ethenyl-4-azabicyclo[2.2.2]oct-5-yl)- (6-methoxyquinolin-4-yl)-methanol
CAS Number	56-54-2
PubChem CID	5953
DrugBank	APRD00136
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H24N2O2
Molar mass	324.417 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For patient information, click here

Quinidine is a pharmaceutical agent that acts as a class I antiarrhythmic agent in the heart. It is a stereoisomer of quinine, originally derived from the bark of the cinchona tree.

Mechanism

Like all other class I antiarrhythmic agents, quinidine primarily works by blocking the fast inward sodium current (I_Na). Quinidine's effect on I_Na is known as a use dependent block. This means that at higher heart rates, the block increases, while at lower heart rates the block decreases. The effect of blocking the fast inward sodium current causes the phase 0 depolarization of the cardiac action potential to decrease (decreased V_max).

Quinidine also blocks the slowly inactivating tetrodotoxin-sensitive Na current, the slow inward calcium current (I_Ca), the rapid (I_Kr) and slow (I_Ks) components of the delayed potassium rectifier current, the inward potassium rectifier current (I_KI), the ATP-sensitive potassium channel (I_KATP) and I_to.

The effect of quinidine on the ion channels is to prolong the cardiac action potential, thereby prolonging the QT interval on the surface ECG.

Elimination

The half life of oral quinidine is 6 to 8 hours, and it is eliminated by the cytochrome P450 system in the liver. About 20 percent is excreted unchanged via the kidneys.

Side effects and other uses

Quinidine is also an inhibitor of the cytochrome P450 enzyme 2D6, and can lead to increased blood levels of lidocaine, Beta blockers, opioids, and some anti-depressants.

Quinidine also inhibits the transport protein P-glycoprotein and so can cause some peripherally acting drugs such as loperamide to have CNS side effects such as respiratory depression if the two drugs are co-administered.

Intravenous quinidine is also indicated for treatment of P. falciparum malaria.

Quinidine-induced thrombocytopenia (low platelet count) is mediated by the immune system, and may lead to thrombocytic purpura.

Quinidine intoxication can lead to a collection of symptoms collectively known as cinchonism with tinnitus (ringing in the ears) being among the most characteristic and common symptoms of this toxicity syndrome.

Quinidine-based ligands are used in AD-mix-β for Sharpless asymmetric dihydroxylation.

References

• MedlinePlus
• Poisons Information Monograph

See also

• Antiarrhythmic agents
• Cardiac action potential

Template:WikiDoc Sources